The US veterinary vaccines market, excluding foot and mouth disease vaccines, showed consistent growth from 2024 to 2028, forecasting a rise from $3.4522 billion to $3.6323 billion. In 2023, this market stood slightly below the $3.4522 billion mark. From 2024 onwards, the market is expected to grow at a steady pace of approximately 1.3% per year, highlighting a positive trend in the sector.
Future trends to watch for include:
- Technological advancements in vaccine development.
- Increasing pet ownership and livestock demand driving vaccine consumption.
- Potential risks from emerging diseases prompting new vaccine formulations.
- Changes in regulatory policies impacting market dynamics.
- Growing emphasis on preventive healthcare for animals.
